Melbourne, 17 April 2007
Siemens Medical Solutions has commissioned the new syngo Dyna CT and iPilot at the Dalcross Private Hospital, the first private hospital in Australia to adopt this new technology for the treatment of vascular disease.
The new syngo Dyna CT and iPilot is the most advanced technology available for Digital Flat Panel Angiography systems and potentially allow patients who have previously been diagnosed as unsuitable for treatment, access to better outcomes.
Siemens Medical Account Manager Diagnostic Imaging, Richard Brookhouse, said collaboration on improvements to angiography systems with medical institutions around the world, led to the development of new features.
“The new syngo Dyna CT has the capability to photograph vessels, such as arteries, and surrounding soft tissues in the human body and display them as 3 dimensional images.
"This capability enables doctors to use the system to treat patients in intervention procedures.
"In many cases, patients will not have to be transferred to another machine for a CT scan as the 3 dimensional images can be displayed during the procedure," said Mr Brookhouse.
The syngo iPilot which is a guidance tool, provides extremely effective 3 dimensional guidance for a doctor during an intervention procedure. Fast effective guidance reduces patient examination time and increases the opportunity for procedural success.
Interventional Neuro-radiologist at the Dalcross hospital, Dr. Ken Faulder, who is a leader in the field of treating stroke and other vascular disease of the brain, said the new Dyna CT improves the accuracy of an intervention procedure to the point where patients previously unsuitable for an angiographic procedure can now be offered treatment.
"Improved technology has seen more people with cerebral aneurysms being offered a minimally invasive angiographic treatment as an alternative to open neurosurgery.
"Clinical trials already show better results than surgery in appropriate patients. These improvements in imaging capabilities will extend even further the number of patients who can be offered this therapy.
"These improvements will also reduce risks and improve intervention procedure outcomes,” said Dr Faulder